• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Generation of fibrinolytic activity by infusion of activated protein C into dogs.通过向犬类输注活化蛋白C产生纤溶活性。
J Clin Invest. 1981 Nov;68(5):1221-8. doi: 10.1172/jci110368.
2
Protein C and fibrinolysis: a link between coagulation and fibrinolysis.蛋白C与纤维蛋白溶解:凝血与纤维蛋白溶解之间的联系。
Adv Exp Med Biol. 1990;281:235-43. doi: 10.1007/978-1-4615-3806-6_23.
3
Mechanism of protein C-dependent clot lysis: role of plasminogen activator inhibitor.蛋白C依赖性血栓溶解机制:纤溶酶原激活物抑制剂的作用
Blood. 1986 Dec;68(6):1218-23.
4
Species specificity of the fibrinolytic effects of activated protein C.活化蛋白C纤溶作用的物种特异性
Thromb Res. 1991 Jul 1;63(1):123-31. doi: 10.1016/0049-3848(91)90275-2.
5
Influence of protein C activation on blood coagulation and fibrinolysis in squirrel monkeys.蛋白C激活对松鼠猴血液凝固和纤维蛋白溶解的影响。
J Clin Invest. 1984 Jul;74(1):200-4. doi: 10.1172/JCI111402.
6
Activation of protein C in vivo.体内蛋白C的激活。
J Clin Invest. 1982 Jul;70(1):127-34. doi: 10.1172/jci110584.
7
Studies on the specific fibrinolytic effect of human extrinsic (tissue-type) plasminogen activator in human blood and in various animal species in vitro.人外源性(组织型)纤溶酶原激活剂在人血液及多种动物体外的特异性纤溶作用研究。
Thromb Haemost. 1981 Aug 28;46(2):561-5.
8
Thrombin activatable fibrinolysis inhibitor (TAFI) does not inhibit in vitro thrombolysis by pharmacological concentrations of t-PA.凝血酶激活的纤溶抑制物(TAFI)不会抑制药理浓度的组织型纤溶酶原激活剂(t-PA)在体外的溶栓作用。
Thromb Haemost. 2001 Apr;85(4):661-6.
9
Activated protein C increases fibrin clot lysis by neutralization of plasminogen activator inhibitor--no evidence for a cofactor role of protein S.活化蛋白C通过中和纤溶酶原激活物抑制剂来增加纤维蛋白凝块的溶解——无证据表明蛋白S具有辅助因子作用。
Thromb Haemost. 1988 Oct 31;60(2):328-33.
10
In vitro studies on the fibrinolytic, thrombolytic and fibrinogenolytic properties of a tissue plasminogen activator from guinea pig keratocytes.豚鼠角膜细胞组织型纤溶酶原激活剂的纤溶、溶栓和纤维蛋白原溶解特性的体外研究。
Thromb Haemost. 1985 Apr 22;53(2):200-3.

引用本文的文献

1
Intraperitoneal administration of activated protein C prevents postsurgical adhesion band formation.腹腔内给予活化蛋白C可预防术后粘连带形成。
Blood. 2015 Feb 19;125(8):1339-48. doi: 10.1182/blood-2014-10-609339. Epub 2015 Jan 9.
2
Regulation of the protein C anticoagulant and antiinflammatory pathways.蛋白 C 抗凝和抗炎途径的调节。
Curr Med Chem. 2010;17(19):2059-69. doi: 10.2174/092986710791233706.
3
Cardiopulmonary bypass in patients with pre-existing coagulopathy.已有凝血功能障碍患者的体外循环
J Extra Corpor Technol. 2005 Mar;37(1):15-22.
4
Modeling zymogen protein C.模拟酶原蛋白C。
Biophys J. 2000 Dec;79(6):2925-43. doi: 10.1016/S0006-3495(00)76530-1.
5
Activated human protein C prevents thrombin-induced thromboembolism in mice. Evidence that activated protein c reduces intravascular fibrin accumulation through the inhibition of additional thrombin generation.活化的人蛋白C可预防小鼠体内凝血酶诱导的血栓栓塞。有证据表明,活化蛋白C通过抑制额外的凝血酶生成来减少血管内纤维蛋白的积累。
J Clin Invest. 1998 Feb 1;101(3):667-76. doi: 10.1172/JCI575.
6
Thrombin-mediated activation of factor XI results in a thrombin-activatable fibrinolysis inhibitor-dependent inhibition of fibrinolysis.凝血酶介导的因子XI激活导致纤溶酶原激活物抑制因子依赖的纤维蛋白溶解抑制。
J Clin Invest. 1997 May 15;99(10):2323-7. doi: 10.1172/JCI119412.
7
The 2.8 A crystal structure of Gla-domainless activated protein C.无γ-羧基谷氨酸结构域的活化蛋白C的2.8埃晶体结构。
EMBO J. 1996 Dec 16;15(24):6822-31.
8
Purpura fulminans in severe congenital protein C deficiency: monitoring of treatment with protein C concentrate.严重先天性蛋白C缺乏症中的暴发性紫癜:蛋白C浓缩物治疗的监测
Eur J Pediatr. 1996 Jan;155(1):20-5. doi: 10.1007/BF02115621.
9
Antithrombotic effects of thrombin-induced activation of endogenous protein C in primates.凝血酶诱导的内源性蛋白C活化在灵长类动物中的抗血栓形成作用。
J Clin Invest. 1993 Oct;92(4):2003-12. doi: 10.1172/JCI116795.
10
[Protein C deficiency--a risk factor for venous thrombosis].蛋白C缺乏——静脉血栓形成的一个危险因素
Klin Wochenschr. 1984 Oct 15;62(20):975-8. doi: 10.1007/BF01728427.

本文引用的文献

1
Studies on the thrombolytic activity of human plasma.人体血浆溶栓活性的研究。
J Clin Invest. 1960 Feb;39(2):426-34. doi: 10.1172/JCI104054.
2
Preparation and properties of bovine factor VIII (antihemophilic factor).牛因子VIII(抗血友病因子)的制备与特性
Biochemistry. 1980 Feb 5;19(3):401-10. doi: 10.1021/bi00544a001.
3
Identification of an endothelial cell cofactor for thrombin-catalyzed activation of protein C.鉴定凝血酶催化蛋白C活化的内皮细胞辅因子。
Proc Natl Acad Sci U S A. 1981 Apr;78(4):2249-52. doi: 10.1073/pnas.78.4.2249.
4
Functional properties of an endothelial cell cofactor for thrombin-catalyzed activation of protein C.一种参与凝血酶催化蛋白C活化的内皮细胞辅因子的功能特性。
J Biol Chem. 1981 Jun 10;256(11):5532-5.
5
A lysine-absorbable plasminogen activator is elevated in conditions associated with increased fibrinolytic activity.一种可吸收赖氨酸的纤溶酶原激活剂在与纤溶活性增加相关的情况下会升高。
J Lab Clin Med. 1981 May;97(5):637-45.
6
Deficiency of protein C inhibitor in combined factor V/VIII deficiency disease.联合因子V/ VIII缺乏症中蛋白C抑制剂缺乏
J Clin Invest. 1980 Nov;66(5):1186-9. doi: 10.1172/JCI109952.
7
Effect of moderate exercise on the fibrinolytic system in normal young men and women.适度运动对正常青年男性和女性纤溶系统的影响。
Br Med J. 1966 Aug 27;2(5512):502-6. doi: 10.1136/bmj.2.5512.502.
8
Plasminogen: purification from human plasma by affinity chromatography.纤溶酶原:通过亲和色谱法从人血浆中纯化。
Science. 1970 Dec 4;170(3962):1095-6. doi: 10.1126/science.170.3962.1095.
9
Protein purification by affinity chromatography. Derivatizations of agarose and polyacrylamide beads.通过亲和色谱法进行蛋白质纯化。琼脂糖和聚丙烯酰胺珠粒的衍生化。
J Biol Chem. 1970 Jun;245(12):3059-65.
10
Cleavage of structural proteins during the assembly of the head of bacteriophage T4.在噬菌体T4头部组装过程中结构蛋白的切割
Nature. 1970 Aug 15;227(5259):680-5. doi: 10.1038/227680a0.

通过向犬类输注活化蛋白C产生纤溶活性。

Generation of fibrinolytic activity by infusion of activated protein C into dogs.

作者信息

Comp P C, Esmon C T

出版信息

J Clin Invest. 1981 Nov;68(5):1221-8. doi: 10.1172/jci110368.

DOI:10.1172/jci110368
PMID:6895378
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC370917/
Abstract

Bovine-activated protein C, administered intravenously to dogs, increases the rate of lysis of whole blood clots. Protein C, bovine prothrombin, and diisopropylfluorophosphate-inactivated protein Ca do not increase the rate of lysis. Repeated infusions of protein Ca sustain rapid blood clot lysis, but neither elevate circulating fibrin-split products nor decrease circulating plasminogen levels. The administration of protein Ca results in the elevation of the levels of lysine-adsorbable plasminogen activator activity in the plasma. When partially purified concentrates of this activator are added to normal dog blood at the levels seen following protein Ca injection, the rate of clot lysis is similar to that seen after protein Ca injection. The addition of protein Ca to citrated whole blood in vitro, with the subsequent neutralization of protein Ca with antibodies, results in increased rates of lysis when plasma made from the treated blood is reinjected into the animal. The generation of fibrinolytic activity is dependent on both cellular and plasma components of blood. A model of protein Ca fibrinolytic activity has a minimum of two components: a secondary messenger formed by protein Ca action on blood cells and plasma, and the subsequent appearance of plasminogen activator in the animal in response to that messenger.

摘要

给狗静脉注射牛活化蛋白C可提高全血凝块的溶解速度。蛋白C、牛凝血酶原和二异丙基氟磷酸酯灭活的蛋白Ca则不会提高溶解速度。重复输注蛋白Ca可维持快速的血凝块溶解,但既不会提高循环纤维蛋白降解产物水平,也不会降低循环纤溶酶原水平。注射蛋白Ca会导致血浆中赖氨酸可吸附的纤溶酶原激活物活性水平升高。当以蛋白Ca注射后所观察到的水平将这种激活物的部分纯化浓缩物添加到正常狗的血液中时,血凝块溶解速度与蛋白Ca注射后相似。在体外将蛋白Ca添加到枸橼酸化全血中,随后用抗体中和蛋白Ca,当将经处理血液制成的血浆重新注入动物体内时,溶解速度会加快。纤溶活性的产生依赖于血液中的细胞成分和血浆成分。蛋白Ca纤溶活性模型至少有两个成分:蛋白Ca作用于血细胞和血浆形成的第二信使,以及动物体内随后因该信使而出现的纤溶酶原激活物。